NRX Pharmaceuticals Inc
NASDAQ:NRXP 4:00:00 PM EDT
| Market Cap (Intraday) | 66.11M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 3.07 |
| 10-Day MA | $2.88 |
| 50-Day MA | $2.79 |
| 200-Day MA | $2.56 |
NRX Pharmaceuticals Inc Stock, NASDAQ:NRXP
1201 Orange Street, Suite 600, Wilmington, Delaware 19801
United States of America
Phone: +1.484.254.6134
Number of Employees:
Description
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.